Paul is a former executive of Sanofi and Eli Lilly. He has a strong visionary perspective and sees how new technologies can be built, utilized, leveraged and commercialized. He has built global development organizations in the US and Europe from the ground up. He has been a key driver in the establishment of several startups. He has worked on and nurtured numerous innovations and built one of the strongest IP portfolios for drug combination products worldwide.